Nykode Therapeutics Employee Directory
Biotechnology ResearchOslo, Norway51-200 Employees
Nykode Therapeutics is a biotechnology company based in Oslo, Norway, focused on immunotherapy discovery and development. It emphasizes an intelligent, modular platform designed to enable targeted therapeutic approaches. Its work spans cancer-related immunotherapies and autoimmune disease research, as reflected in its clinical investigations and collaborations. As a clinical-stage biopharmaceutical company, it pursues translational programs aimed at delivering innovative immune-based treatments to patients. In January 2026, Barbara Krebs-Pohl was appointed chair of the board, with remuneration for the board approved. Earlier, the company disclosed a collaboration with MSD to evaluate VB10.16 in combination with pembrolizumab for a cervical cancer indication, illustrating its engagement with established partners to advance therapies.